Company Profile | February 28, 2014

2014 CRO Leadership Awards Winner

parexel logo

Categories Won:

  1. Quality

  2. Reliability

  3. Regulatory

  4. Productivity

  5. Innovation

 

Drug Life Cycle Stages:

Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3)

Main Service Areas:
Clinical

Services & Capabilities:
PAREXEL offers worldwide regulatory expertise, Phase I-IV clinical research services, eClinical technologies that accelerate development, and integrated commercialization services. The company
delivers best-practice outsourcing models focused on significant value creation.

Therapeutic Areas:
PAREXEL has expertise across a broad range of therapeutic areas including oncology, cardiology, neurology, metabolism/endocrine, and infectious disease.

Josef Von Rickenbach

chairman and CEO

“The drug development process is a journey with many challenges, and PAREXEL has evolved to meet these complex changes and help bring these important new drugs to market, efficiently and reliably. Navigating regulatory constraints, patient recruitment challenges, data collection, and payer demands is increasingly complex. PAREXEL’s goal is to help biopharmaceutical companies create and build the shortest journey from science to new treatments.”